These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 432958

  • 1. [Functional activity of the lymphocytes of mouse lymph nodes in a system of viral carcinogenesis].
    Umanskiĭ IuA, Evsev'eva AI, Semenova-Kobzar' RA, Kushko LIa.
    Tsitologiia; 1979 Feb; 21(2):191-5. PubMed ID: 432958
    [Abstract] [Full Text] [Related]

  • 2. Cell-mediated immune reaction against tumors induced by oncornaviruses. 3. Studies by mixed lymphocyte-tumor reaction.
    Senik A, Gomard E, Plata F, Levy JP.
    Int J Cancer; 1973 Jul 15; 12(1):233-41. PubMed ID: 4133585
    [No Abstract] [Full Text] [Related]

  • 3. Antigenic specificities of the cellular immune response of C57BL/6 mice to the Moloney leukemia/sarcoma virus complex.
    Enjuanes L, Lee JC, Ihle JN.
    J Immunol; 1979 Feb 15; 122(2):665-74. PubMed ID: 84033
    [No Abstract] [Full Text] [Related]

  • 4. [Antitumor activity of the serum and lymphocytes of C57BL mice in chemical carcinogenesis].
    Umanskiĭ IuA, Kushko LIa, Semenova-Kobzar' RA.
    Vopr Onkol; 1980 Feb 15; 26(2):42-6. PubMed ID: 7361493
    [Abstract] [Full Text] [Related]

  • 5. Mechanisms in T cell leukemogenesis. II. T cell responses of preleukemic BALB/c mice to Moloney leukemia virus antigens.
    Lee JC, Horak I, Ihle JN.
    J Immunol; 1981 Feb 15; 126(2):715-22. PubMed ID: 6969759
    [Abstract] [Full Text] [Related]

  • 6. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus.
    Wood GW.
    Cancer Res; 1976 Dec 15; 36(12):4552-7. PubMed ID: 1000500
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Alteration of cellular ribonucleases associated with murine oncogenic virus infection.
    Drake WP, Frazier LM, Sidle D, Mardiney MR.
    Biomedicine; 1978 Dec 15; 28(1):24-8. PubMed ID: 208672
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC, Shiu G, Rodrigues D, Herberman RB.
    Cancer Res; 1974 Jul 15; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract] [Full Text] [Related]

  • 11. Immunity to tumours of the murine leukaemia-sarcoma virus complex.
    Owen JJ, Seeger RC.
    Br J Cancer Suppl; 1973 Aug 15; 1():26-34. PubMed ID: 4374230
    [Abstract] [Full Text] [Related]

  • 12. Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s).
    Lamon EW, Skurzak HM, Andersson B, Whitten HD, Klein E.
    J Immunol; 1975 Apr 15; 114(4):1171-6. PubMed ID: 1117138
    [Abstract] [Full Text] [Related]

  • 13. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D, Ronchese F, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1982 Feb 15; 128(2):774-9. PubMed ID: 6459385
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. T cell recognition of Moloney leukemia virus proteins. III. T cell proliferative responses against gp70 are associated with the production of a lymphokine inducing 20 alpha-hydroxysteroid dehydrogenase in splenic lymphocytes.
    Ihle JN, Lee JC, Rebar L.
    J Immunol; 1981 Dec 15; 127(6):2565-70. PubMed ID: 6795277
    [Abstract] [Full Text] [Related]

  • 17. Immunosuppression in a murine B cell leukemia (BCL1): role of an adherent cell in the suppression of primary in vitro antibody responses.
    Anderson SA, Isakson PC, Puré E, Muirhead M, Uhr JW, Vitetta ES.
    J Immunol; 1981 Apr 15; 126(4):1603-7. PubMed ID: 6451649
    [Abstract] [Full Text] [Related]

  • 18. The activity of regional nodes in the evolution of immune responses to allogeneic and isogeneic tumors.
    Barna B, Deodhar SD.
    Cancer Res; 1975 Apr 15; 35(4):920-6. PubMed ID: 1116149
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.